William N. Bell

412 total citations
8 papers, 323 citations indexed

About

William N. Bell is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, William N. Bell has authored 8 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in William N. Bell's work include Colorectal Cancer Treatments and Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Treatment and Pharmacology (2 papers). William N. Bell is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Treatment and Pharmacology (2 papers). William N. Bell collaborates with scholars based in United States and Canada. William N. Bell's co-authors include Linda M. Thurmond, Theodore F. Logan, Michael J. Robertson, Kevin M. Koch, Lyndon C. Kirby, Mohammed M. Dar, Steven J. Kathman, Jill Weisenbach, John M. Kirkwood and James W. Mier and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and In Vitro Cellular & Developmental Biology - Plant.

In The Last Decade

William N. Bell

8 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William N. Bell United States	7	181	166	132	37	25	8	323
Nicholas D’Cunha United States	9	151 0.8×	103 0.6×	85 0.6×	37 1.0×	28 1.1×	32	282
Florian Schenck Germany	8	244 1.3×	95 0.6×	96 0.7×	23 0.6×	19 0.8×	12	325
Jeffrey Schlom United States	9	174 1.0×	164 1.0×	122 0.9×	51 1.4×	38 1.5×	11	391
Yumiko Higuchi Japan	10	167 0.9×	166 1.0×	92 0.7×	48 1.3×	22 0.9×	30	305
Jessica Cantrell United States	8	160 0.9×	291 1.8×	78 0.6×	22 0.6×	18 0.7×	10	396
Anasuya Gunturi United States	9	345 1.9×	339 2.0×	187 1.4×	48 1.3×	15 0.6×	10	585
Alessandra Jales United States	6	137 0.8×	144 0.9×	118 0.9×	42 1.1×	10 0.4×	6	329
Diane Feingersh United States	2	395 2.2×	229 1.4×	85 0.6×	101 2.7×	14 0.6×	2	516
Tarsem Moudgil United States	7	207 1.1×	173 1.0×	62 0.5×	19 0.5×	12 0.5×	10	278
Mikiya Ishihara Japan	8	146 0.8×	100 0.6×	65 0.5×	36 1.0×	29 1.2×	35	234

Countries citing papers authored by William N. Bell

Since Specialization

Citations

This map shows the geographic impact of William N. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William N. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William N. Bell more than expected).

Fields of papers citing papers by William N. Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William N. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William N. Bell. The network helps show where William N. Bell may publish in the future.

Co-authorship network of co-authors of William N. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of William N. Bell. A scholar is included among the top collaborators of William N. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William N. Bell. William N. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Robertson, Michael J., John M. Kirkwood, Theodore F. Logan, et al.. (2008). A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer. Clinical Cancer Research. 14(11). 3462–3469. 94 indexed citations

Olson, Luke N. & William N. Bell. (2008). Algebraic multigrid for discrete differential forms. 9 indexed citations

Robertson, Michael J., James W. Mier, Theodore F. Logan, et al.. (2006). Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer. Clinical Cancer Research. 12(14). 4265–4273. 126 indexed citations

Lewis, Nicole, Jared Gollob, Roger B. Cohen, et al.. (2004). Phase I dose escalation study to assess tolerability and pharmacokinetics of recombinant human IL-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2591–2591. 1 indexed citations

Schilsky, Richard L., Jeremey Levin, William H. West, et al.. (2002). Randomized, Open-Label, Phase III Study of a 28-Day Oral Regimen of Eniluracil Plus Fluorouracil Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Therapy in Patients With Metastatic/Advanced Colorectal Cancer. Journal of Clinical Oncology. 20(6). 1519–1526. 32 indexed citations

Mani, Sridhar, Howard S. Höchster, Thomas Beck, et al.. (2000). Multicenter Phase II Study to Evaluate a 28-Day Regimen of Oral Fluorouracil Plus Eniluracil in the Treatment of Patients With Previously Untreated Metastatic Colorectal Cancer. Journal of Clinical Oncology. 18(15). 2894–2901. 35 indexed citations

Bell, William N., et al.. (1993). Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.. PubMed. 53(3). 500–8. 18 indexed citations

Grisham, Joe W., et al.. (1978). Differing effects of isoleucine deficiency on the toxicity of MNNG for 10T1/2 and CHO cells. In Vitro Cellular & Developmental Biology - Plant. 14(6). 516–521. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact